ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 630599 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 630599; 2) Community: the network communities that were significantly associated with the response to NSC 630599; 3) Molecule: the relationships between components within communities and NSC 630599; 4) MDR: the compounds that were significantly associated with the NSC 630599.

NSC Compound Enrichment Correlation
NSC 254681 5(8H)-Naphthacenone, 8-acetyl-10-[(3-amino-2,3,6-trideoxy- .alpha.-L-lyxo-hexopyranosyl)oxy]-7,9,10,12-tetrahydro-6,8,~ 11-trihydroxy-12-imino-1-methoxy-, monohydrochloride, (8S-cis)- (9CI) 0.0133299224082802 0.29251327
NSC 26273 6-Benzylthioinosine 0.0133299224082802 0.40817763
NSC 363812 Tetraplatin 0.0133299224082802 0.4298043
NSC 373980 Null 0.0133299224082802 0.38913928
NSC 38643 Lenamycin 0.0133299224082802 0.43030066
NSC 39202 Cyclohexanone, 2,6-bis(piperidinomethyl)- 0.0133299224082802 0.46764678
NSC 621335 Null 0.0133299224082802 0.33363473
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.0133299224082802 0.53089917
NSC 628915 3-(2-N,N-diethylaminoethylamino)-1,2,4-benzotriazine 1,4-dioxide. Hemihydrate 0.0133299224082802 0.26374346
NSC 629974 7H-1,2,4-Triazolo[3,4-b][1,3,4]thiadiazine, 3-(4-chlorophenyl)-6-(5-nitro-2-furanyl)- (9CI) 0.0133299224082802 0.48894963
Total:157  Current:76    [First] [Prev] [Next] [Last]